학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,451건 | 목록 1~20
Academic Journal
IEEE Geoscience and Remote Sensing Letters IEEE Geosci. Remote Sensing Lett. Geoscience and Remote Sensing Letters, IEEE. 22:1-5 2025
Academic Journal
Di Federico A; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Harvard Medical School, Boston, MA, USA.; Wang K; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen MF; Early Drug Development and Melanoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Barsouk AA; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Pagliaro A; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Chen LN; Columbia University Irving Medical Center, New York, NY, USA.; Ogliari FR; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.; Stockhammer P; Section of Medical Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT, USA.; Thawani R; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Raslan S; Department of Internal Medicine, Henry Ford Health, Detroit, MI, USA.; Gariazzo E; Medical Oncology, Santa Maria Della Misericordia Hospital, Perugia, Italy.; Fusco F; IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Hambelton GM; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Citarella F; Research Unit of Oncology, Department of Medicine and Surgery, Campus Bio-Medico University of Rome, Rome, Italy; Medical Oncology Department, IRCCS Romagna Institute for the Study of Tumours 'Dino Amadori', Meldola, Italy.; Meyer D; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Aldea M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; De Giglio A; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Alessi JV; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Pecci F; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Gelsomino F; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Corassa M; Thoracic Oncology Unit, BP-A Beneficência Portuguesa de São Paulo, São Paulo, Brazil.; Vokes NI; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang X; Department of Environmental Health, Harvard T H Chan School of Public Health, Harvard University, Boston, MA, USA.; de Biase D; Solid Tumor Molecular Pathology Laboratory, IRCCS University Hospital of Bologna, Bologna, Italy; Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy.; Abu Rous F; Department of Internal Medicine, Henry Ford Health, Detroit, MI, USA; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Health, Detroit, MI, USA.; Areesawangkit P; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Elghawy O; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Cortellini A; Research Unit of Oncology, Department of Medicine and Surgery, Campus Bio-Medico University of Rome, Rome, Italy; Operative Research Unit of Medical Oncology, Campus Bio-Medico University Hospital Foundation, Rome, Italy.; Metro G; Medical Oncology, Santa Maria Della Misericordia Hospital, Perugia, Italy.; Ferrara R; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.; Awad MM; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Pabani A; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Murray JC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Cappuzzo F; IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Garassino MC; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.; Dagogo-Jack I; Harvard Medical School, Boston, MA, USA; Center for Thoracic Cancers, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Riely G; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Grant M; Section of Medical Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT, USA.; Herzberg BO; Columbia University Irving Medical Center, New York, NY, USA.; Ardizzoni A; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Planchard D; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Johnson BE; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Langer CJ; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Offin M; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Negrao MV; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ricciuti B; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: biagio_ricciuti@dfci.harvard.edu.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
Nokin MJ; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium. Electronic address: mjnokin@uliege.be.; Darbo E; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France.; Richard E; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France.; San José S; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain.; de Hita S; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain.; Prouzet-Mauleon V; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; CRISP'edit, TBMCore, University of Bordeaux, CNRS UAR 3427, INSERM US05, 33000 Bordeaux, France.; Turcq B; Bordeaux Institute of Oncology (BRIC), INSERM U1312, University of Bordeaux, 33000 Bordeaux, France; CRISP'edit, TBMCore, University of Bordeaux, CNRS UAR 3427, INSERM US05, 33000 Bordeaux, France.; Gerardelli L; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium.; Crake R; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium.; Velasco V; Department of Biopathology, Institut Bergonié, 33076 Bordeaux, France.; Koopmansch B; Department of Human Genetics, University Hospital Center of Liege, 4000 Liege, Belgium.; Lambert F; Department of Human Genetics, University Hospital Center of Liege, 4000 Liege, Belgium.; Xue JY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Sang B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Horne J; Laboratory of Pharmaceutical Analytical Chemistry, CIRM, University of Liege, 4000 Liege, Belgium.; Ziemons E; Laboratory of Pharmaceutical Analytical Chemistry, CIRM, University of Liege, 4000 Liege, Belgium.; Villanueva A; Chemoresistance and Predictive Factors Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO); Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, 08908 Barcelona, Spain.; Blomme A; Laboratory of Cancer Signaling, GIGA-Stem Cells, University of Liege, 4000 Liege, Belgium.; Herfs M; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, 4000 Liege, Belgium.; Cataldo D; Laboratory of Biology of Tumor and Development (LBTD), GIGA-Cancer, University of Liege, 4000 Liege, Belgium.; Calvayrac O; Cancer Research Centre of Toulouse, INSERM UMR1037, CNRS UMR5071, 31100 Toulouse, France.; Porporato P; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy.; Nadal E; Molecular Mechanisms of Cancer Program, Department of Medical Oncology, Catalan Institute of Oncology (ICO), Preclinical and Experimental Research in Thoracic Tumors (PReTT) Group, Oncobell Program, IDIBELL, L'Hospitalet del Llobregat, 08908 Barcelona, Spain.; Lito P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ricciuti B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Awad MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, 10126 Torino, Italy. Electronic address: chiara.ambrogio@unito.it.; Santamaría D; University of Bordeaux, INSERM U1218, ACTION Laboratory, IECB, 33600 Pessac, France; Centro de Investigación del Cáncer, CSIC-Universidad de Salamanca, 37007 Salamanca, Spain. Electronic address: d.santamaria@usal.es.
Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
Academic Journal
Huang HC; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX 75390, USA.; Deng Q; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX 75390, USA.; Guo L; Quantitative Biomedical Research Center, Department of Population & Data Sciences, Dallas, TX 75390, USA.; Gorria T; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Yang D; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX 75390, USA.; Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.; De Las Casas L; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Hallin J; Mirati Pharmaceuticals (a Bristol Myers Squibb company), San Diego, CA 92121, USA.; Christensen JG; Mirati Pharmaceuticals (a Bristol Myers Squibb company), San Diego, CA 92121, USA.; Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Xu L; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX 75390, USA.; Quantitative Biomedical Research Center, Department of Population & Data Sciences, Dallas, TX 75390, USA.; Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA.; Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Akbay EA; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX 75390, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
ANNALS OF ONCOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Annals of oncology, Vol. 32, no.11, p. 1391-1399 (2021)
Academic Journal
Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Agrawal P; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Ross JS; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nakazawa S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Aldea M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Garbo E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Santo V; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gariazzo E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Makarem M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Haradon D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Odintsov I; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Baine M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Travis W; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Yang SR; Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard University, Cambridge, Boston, Massachusetts.; Ugalde Figueroa PA; Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard University, Cambridge, Boston, Massachusetts.; Gray KD; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Nishino M; Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.; Mayoral Penalva M; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Sholl LM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Awad MM; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: awadm3@mskcc.org.; Chaft JE; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ricciuti, B.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어